 |
 |

Arachidonic Acid: A Common Link in the Biology of Schizophrenia?
M. Peet, MB, FRCPsych;
J. D. E. Laugharne, MB, MRCPsych
Department of Psychiatry Northern General Hospital Herries Road Sheffield, England S5 7AU
D. F. Horrobin, DPhil
Kentville, Nova Scotia
G. P. Reynolds, PhD
Western Bank, Sheffield, England
Arch Gen Psychiatry. 1994;51(8):665-666.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
There is evidence of abnormalities of prostaglandin synthesis and action in schizophrenia; thus, there are reports of increased activity of phospholipase A2,1 increased plasma levels of prostaglandin E2,2 and subsensitivity of platelet prostaglandin receptors.3 The main precursor for prostaglandin synthesis is arachidonic acid, which is released from membrane phospholipid by phospholipase A2. One possible consequence of increased phospholipase A2 activity would be the depletion of arachidonic acid.
In the course of a study of membrane fatty acids, we measured4 red blood cell membrane arachidonic acid in a group of 23 hospitalized neuroleptic-treated schizophrenic patients (16 men and 7 women) aged 28 to 75 years (mean age, 55 years) and 16 control subjects matched for age and sex. We also measured the plasma levels of thiobarbituric acid reactive substances (TBARS) in the same blood samples. Thiobarbituric acid reactive substances are a measure of
. . . [Full Text PDF of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|